Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
| Short Descr | ONC SLD ORGN TGSA DNA 84/+ | Medium Descr | ONC SLD ORGN TGSA FFPE TUM TISS DNA 84/+ GENES | Long Descr | Oncology (solid organ), targeted genomic sequence analysis, formalin-fixed paraffin-embedded (FFPE) tumor tissue, DNA analysis, 84 or more genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability and tumor mutational burden | CLIA Waived (QW) | No | APC Status Indicator | Service Paid under Fee Schedule or Payment System other than OPPS | Berenson-Eggers TOS (BETOS) | none | MUE | 1 |
| GA | Waiver of liability statement issued as required by payer policy, individual case |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2024-01-01 | Changed | Medium Description Changed |
| 2023-01-01 | Added | First appearance in codebook. |
| 2022-10-01 | Added | Code added. |
Get instant expert-level medical coding assistance.